Clinical evaluation of super-responders vs. non-responders to CGRP(-receptor) monoclonal antibodies: a real-world experience

BACKGROUND: Clinical trials and real-world studies revealed a spectrum of response to CGRP(-receptor) monoclonal antibodies (mAbs) in migraine prophylaxis, ranging from no effect at all to total migraine freedom. In this study, we aimed to compare clinical characteristics between super-responders (S...

Descripción completa

Detalles Bibliográficos
Autores principales: Raffaelli, Bianca, Fitzek, Mira, Overeem, Lucas H., Storch, Elisabeth, Terhart, Maria, Reuter, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969617/
https://www.ncbi.nlm.nih.gov/pubmed/36843007
http://dx.doi.org/10.1186/s10194-023-01552-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969617/
https://www.ncbi.nlm.nih.gov/pubmed/36843007
http://dx.doi.org/10.1186/s10194-023-01552-x

Ejemplares similares